Hims & Hers Health GAAP EPS of $0.32 beats by $0.27, revenue of $401.6M beats by $18.83M

seekingalpha
2024-11-05
  • Hims & Hers Health press release (NYSE:HIMS): Q3 GAAP EPS of $0.32 beats by $0.27.
  • Revenue of $401.6M (+77.2% Y/Y) beats by $18.83M.
  • Hims & Hers is providing the following guidance:

  • For the fourth quarter 2024, the company expects:

  • Revenue of $465 million to $470 million vs $421.11M consensus

  • Adjusted EBITDA of $50 million to $55 million, reflecting an Adjusted EBITDA margin of 11% to 12%.

  • For the full year 2024, expects:

  • Revenue of $1.460 billion to $1.465 billion vs $1.40B consensus

  • Adjusted EBITDA of $173 million to $178 million, reflecting an Adjusted EBITDA margin of 12%.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10